Paper Details

  1. Home
  2. Paper Details

Clinical guidance for the use of dupilumab in eosinophilic esophagitis: A yardstick.

Author: AcevesSeema S, DellonEvan S, GreenhawtMatthew, HiranoIkuo, LiacourasChris A, SpergelJonathan M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This expert opinion document provides a framework for how clinicians can consider using dupilumab, the first medication approved for the treatment of eosinophilic esophagitis (EoE), in the treatment strategy for patients with EoE.
Paper Details　
Original Abstract of the Article :
The Joint Task Force for the American Academy of Allergy Asthma Immunology and American College of Allergy Asthma Immunology and the American Gastroenterology Association recently published guidelines for the management of eosinophilic esophagitis (EoE). Because the guideline was published, dupiluma...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.anai.2022.12.014

データ提供：米国国立医学図書館（NLM）

Dupilumab: A New Tool for Treating Eosinophilic Esophagitis

Eosinophilic esophagitis (EoE), a chronic inflammatory condition affecting the esophagus, can make swallowing difficult. This research explores the use of dupilumab, a newly approved medication for treating EoE.

Dupilumab Offers a Novel Treatment Option

The research focuses on providing clinical guidance for using dupilumab in the treatment of EoE. It discusses how this medication can be integrated into a comprehensive treatment strategy for patients with EoE.

A Camel's Perspective on EoE

This research is a testament to the ongoing advancements in medicine, offering new hope for those struggling with EoE. Dupilumab represents a promising addition to the toolkit for treating this condition, emphasizing the importance of staying informed about new treatment options.

Dr. Camel's Conclusion

This research provides valuable guidance for using dupilumab in the treatment of EoE, offering a new avenue for managing this challenging condition. It's a reminder that the field of medicine is constantly evolving, offering new possibilities for improving patient health and well-being.

Date :
  1. Date Completed 2023-03-07
  2. Date Revised 2023-03-14
Further Info :

Pubmed ID

36521784

DOI: Digital Object Identifier

10.1016/j.anai.2022.12.014

Related Literature

Article Analysis
・Effective treatment of eosinophilic disorders
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.